Elon Musk's Brain Implant Company Neuralink Announces FDA Approval of In-Human Clinical Study

No BCI company has managed to clinch the FDA's final seal of approval. But by receiving the go-ahead for a study with human patients, Neuralink is one step closer to market.

Neuralink's BCI will require patients to undergo invasive brain surgery. Its system centers around the Link, a small circular implant that processes and translates neural signals. The Link is connected to a series of thin, flexible threads inserted directly into the brain tissue where they detect neural signals.

Patients with Neuralink devices will learn to control it using the Neuralink app. Patients will then be able to control external mice and keyboards through a Bluetooth connection, according to theThe FDA's approval for an in-human study is a significant win for Neuralink after a series of recent hurdles at the company. In February, the U.S.

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

Elon Musk’s brain chip company Neuralink gets FDA approval: What to knowNeuralink said it has regulatory approval to conduct a clinical trial of its brain implants in people, a milestone for the company as it seeks to commercialize a device that will link human brains to computers.
ソース: washingtonpost - 🏆 95. / 72 続きを読む »

Elon Musk's brain-implant company Neuralink says it has FDA approval for first human clinical studyElon Musk’s Neuralink said Thursday it has received regulatory approval to start the first in-human clinical study for its brain implant.
ソース: MarketWatch - 🏆 3. / 97 続きを読む »